US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

A tiny Danish town of 16,000 people, for example, is experiencing an incredible change thanks to Ozempic and other weight ...

A urologist has explained the true reality of 'Ozempic penis' as men report a side effect of the weight loss drug ...

Semaglutide generics set to enter the Canadian market by 2026 after Novo Nordisk failed to maintain key patent | Speculation ...

Both Fischel and La Bomba Pharmacies have asked their diabetic customers to schedule a free screening as part of a collaborative program where Ainnova will use its cutting-edge AI platform, Vision AI, ...

Indian pharmaceutical companies are preparing to flood the market with generic versions of Novo Nordisk’s semaglutide—sold ...

Novo Nordisk, the maker of Ozempic and Wegovy, is predicted to lose billions in profits due to a minor billing error in ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

Filipino doctors are calling for more public awareness to treat obesity as a chronic disease, not merely as a lifestyle ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...